Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiovascular Disease and Lipid Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04274777
What this trial is testing

The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders

Who this might be right for
Traumatic Brain InjuryCoagulation Disorder
Tang-Du Hospital 100
Post-approval studies (Phase 4)Study completedNCT00174330
What this trial is testing

Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia

Who this might be right for
HypertensionHyperlipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 330
Not applicableStudy completedNCT06423365
What this trial is testing

A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.

Who this might be right for
Hydroxymethylglutaryl-CoA Reductase InhibitorsHypercholesterolemiaCardiovascular Diseases+2 more
University of Utah 898
Not applicableStudy completedNCT01744392
What this trial is testing

Medication Adherence With Polyglot Meducation

Who this might be right for
HypertensionDiabetesHypercholesterolemia
Durham VA Medical Center 23
Not applicableActive Not RecruitingNCT05339841
What this trial is testing

Italian Digital Primary Cardiovascular Prevention Study

Who this might be right for
Healthy Population
Centro Cardiologico Monzino 27,520
Testing effectiveness (Phase 2)Ended earlyNCT03773172
What this trial is testing

Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism

Who this might be right for
Cardiovascular Diseases
Columbia University 7
Post-approval studies (Phase 4)Study completedNCT01190007
What this trial is testing

Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients

Who this might be right for
HypertensionHypercholesterolemiaAngina Pectoris
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 159
Not applicableStudy completedNCT00822471
What this trial is testing

Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program at an Urban Public Library

Who this might be right for
DiabetesCardiovascular Disease
Medstar Health Research Institute 360
Large-scale testing (Phase 3)UnknownNCT04806893
What this trial is testing

Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction

Who this might be right for
Cardiovascular Risk FactorCardiovascular DiseasesCardiovascular Stroke+1 more
LIB Therapeutics LLC 900
Post-approval studies (Phase 4)Looking for participantsNCT06501443
What this trial is testing

LATAM LOWERS LDL-C

Who this might be right for
Hypercholesterolaemia
Novartis Pharmaceuticals 520
Not applicableUnknownNCT03483155
What this trial is testing

Compliance With The European Society Of Cardiology Prevention Guidelines In Patients at High Cardiovascular Disease Risk

Who this might be right for
HypertensionDiabetesDyslipidemias
Assiut University 50
Not applicableStudy completedNCT03330548
What this trial is testing

Pilot Study on the Effects of a Plant-Strong Diet on Cardiovascular Risk Factors

Who this might be right for
HyperlipidemiasOverweight and ObesityDiabetes
Phoenix VA Health Care System 87
Large-scale testing (Phase 3)Ended earlyNCT00965055
What this trial is testing

Ezetimibe in Patients Hypo-responsive to Statins

Who this might be right for
High CholesterolCoronary Artery Disease
University of California, San Diego 2
Not applicableUnknownNCT04015726
What this trial is testing

Secular Trends in the Prevalence of Cardiometabolic Risk Factors Among Teenage School Children in Urban South India

Who this might be right for
ObesityDysglycemiaDyslipidemias+2 more
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals 2,815
Not applicableStudy completedNCT05450575
What this trial is testing

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet

Who this might be right for
HypertensionDyslipidemia
Hanmi Pharmaceutical Company Limited 5,400
Not applicableLooking for participantsNCT07382128
What this trial is testing

Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes

Who this might be right for
HCM - Hypertrophic CardiomyopathyAnderson Fabry DiseaseCardiac Magnetic Resonance Imaging+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 250
Not applicableLooking for participantsNCT07543731
What this trial is testing

A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

Who this might be right for
Cardiovascular DiseasesAtherosclerotic Cardiovascular DiseaseHypercholesterolemia, Familial
Novartis Pharmaceuticals 5,995
Early research (Phase 1)Study completedNCT01842256
What this trial is testing

Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.

Who this might be right for
Essential HypertensionHyperlipidemia
Chong Kun Dang Pharmaceutical 24
Not applicableUnknownNCT02261441
What this trial is testing

Cardiovascular and Renal Risk in Spain

Who this might be right for
Cardiovascular Disease
La Sociedad Española de Médicos de Atención Primaria 15,000
Testing effectiveness (Phase 2)UnknownNCT06114329
What this trial is testing

Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease

Who this might be right for
Fabry Disease
AceLink Therapeutics, Inc. 16
Next Page